September 15, 2020
In 2015, the U.S. FDA revised guidance for blood donor deferral of men
who have sex with men (MSM) from an indefinite to a 12-month deferral;
in April of 2020, the deferral was shortened to 3 months. In order to
determine if the change from indefinite to a 12-month deferral led to an
increase in the risk [Read More]
|
September 9, 2020
On September 1, 2020, shortly after the U.S. Food and Drug’s Emergency
Use Authorization (EUA) for the use of COVID-19 convalescent plasma
(CCP), the U.S. National Institutes of Health (NIH) issued a statement
urging for more randomized controlled trials for CCP. The NIH Panel’s
statement [Read More] |
No comments:
Post a Comment